{
  "slug": "5-htp",
  "version": "1",
  "displayName": "5-HTP",
  "unit": "mg",
  "doseKind": "compound",
  "ingredientGroups": [
    "5-HTP"
  ],
  "shelfComparable": true,
  "primaryFloorId": "mood-50",
  "trialFloors": [
    {
      "id": "mood-50",
      "label": "Depression trial in Parkinson's disease (50 mg/day)",
      "presetLabel": "Meloni 2020",
      "amount": 50,
      "frequency": "daily",
      "horizon": "4 weeks",
      "evidenceLevel": "limited",
      "palette": "research",
      "pmids": [
        "32067288"
      ],
      "n": 25,
      "note": "50 mg/day for 4 weeks in a randomized double-blind placebo-controlled crossover trial in Parkinson's disease depression; significant HDRS improvement, no effect on apathy, and the authors call it preliminary. A single small trial in one population, cited by our 5-HTP with SSRIs guide.",
      "effectDirection": "weak-benefit",
      "referenceKind": "single-trial",
      "funding": "not-stated"
    },
    {
      "id": "addon-300",
      "label": "Antidepressant add-on (300 mg/day)",
      "presetLabel": "Nardini 1983",
      "amount": 300,
      "frequency": "daily",
      "horizon": "28 days",
      "evidenceLevel": "limited",
      "palette": "research",
      "pmids": [
        "6381336"
      ],
      "n": 26,
      "note": "300 mg/day added to chlorimipramine 50 mg/day in hospitalized depression, double-blind against chlorimipramine plus placebo, for 28 days. Two patients on chlorimipramine plus placebo dropped out. Supervised add-on context only, never a basis for stacking on top of serotonergic medication without a prescriber.",
      "effectDirection": "benefit",
      "referenceKind": "single-trial",
      "funding": "not-stated"
    },
    {
      "id": "appetite-900",
      "label": "Obesity trial (900 mg/day)",
      "presetLabel": "Cangiano 1992",
      "amount": 900,
      "frequency": "daily",
      "horizon": "two consecutive 6-wk periods",
      "evidenceLevel": "limited",
      "palette": "research",
      "pmids": [
        "1384305"
      ],
      "n": 20,
      "note": "900 mg/day in 20 obese adults randomly assigned to 5-HTP or placebo, across two consecutive double-blind 6-week periods. No diet was prescribed during the first period. A 5040-kJ/d diet was recommended for the second. Significant weight loss, lower carbohydrate intake, and earlier satiety were seen on 5-HTP during both periods. The authors report good tolerance.",
      "effectDirection": "weak-benefit",
      "referenceKind": "single-trial",
      "funding": "not-stated"
    }
  ],
  "guideSlugs": [
    "5-htp-with-ssris",
    "winter-blues-supplements"
  ],
  "guideUrls": [
    "https://supplementbrief.com/5-htp-with-ssris/",
    "https://supplementbrief.com/winter-blues-supplements/"
  ],
  "shelf": null,
  "updatedDate": "2026-11-14",
  "dosePageUrl": "https://supplementbrief.com/dose/5-htp/",
  "jsonUrl": "https://supplementbrief.com/data/v1/doses/5-htp.json",
  "htmlUrl": "https://supplementbrief.com/data/v1/doses/5-htp/"
}
